Search results
Results from the WOW.Com Content Network
Mercury was also used for psoriasis treatment during this time. [130] Sulfur, iodine, and phenol were also commonly used treatments for psoriasis during this era when it was incorrectly believed that psoriasis was an infectious disease. [130] Coal tars were widely used with ultraviolet light irradiation as a topical treatment approach in the ...
Psoriasis, a chronic skin condition that causes inflammation in the form of raised plaques and scales on the body, affects more than 3% of the U.S. adult population. Symptoms often begin between ...
Psoriatic erythroderma can be congenital or secondary to an environmental trigger. [12] [13] [14] Environmental triggers that have been documented include sunburn, skin trauma, psychological stress, systemic illness, alcoholism, drug exposure, chemical exposure (e.g., topical tar, computed tomography contrast material), and the sudden cessation of medication.
The underlying process in psoriatic arthritis is inflammation; therefore, treatments are directed at reducing and controlling inflammation. The first-line initial treatment for most patients is a TNF inhibitor-type biological disease-modifying anti-rheumatic drug (DMARD). [30] [6] The goal of treatment is to achieve minimal or low disease activity.
The Good News About Psoriasis. THE FDA HAS approved 13 different “biologic” drugs—those that act on your immune system—for the treatment psoriasis so far. Yes, 13 is a lot, but a doc can ...
For premium support please call: 800-290-4726 more ways to reach us
Various ototoxic effects are manifested by using antimalarial drugs, with dizziness being one of the most common one. Other effects include vestibular symptoms, hearing loss and tinnitus, which can appear to be both temporary or permanent. [25] Nonetheless, the underlying mechanisms of antimalarial-induced ototoxicity are still poorly understood.
The most common side effects include upper respiratory infections, injection site reactions and fungal infections. [12] The drug was developed by Eli Lilly and Co. and is approved for the treatment of plaque psoriasis in the European Union and the United States as of 2016. [6] [13]